Follow The Filings

EVLV Evolv Technologies Hldngs In

Information Technology, filed as EVOLV TECHNOLOGIES HLDNGS IN (COM CL A), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.3%
  • $2.3M
  • 1 add

In 2026 Q2 Torray Investment Partners added to Evolv Technologies Hldngs In.

Who owns this now

Largest portfolio weights among holders, up to 0.3% (Torray Investment Partners). Not free-float ownership.

  1. Torray Investment Partners Add 0.31%

Who owns EVLV

Sorted by value, long equity only, as of 2026 Q2.

History
Torray Investment Partners 0.31% Add +11.1% 392,714 $2.3M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by EVLV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All EVLV insider trades
  • $750K bought by 6 insiders
  • None no sales outside a trading plan
  • $7.8M sold by 2 insiders under 10b5-1 plans
  1. Richard A Shapiro Director
    Buy
    $162K 32,600 shares at $4.96
    Traded Sep 4 Filed Sep 9
    ↗
  2. Michael Ellenbogen Director
    Planned sale
    $451K 80,752 shares at $5.59 3.7% of stake
    Traded Aug 17 Filed Aug 19
    ↗
  3. Henrik Kuhl Director
    Buy
    $86K 15,000 shares at $5.73 New stake
    Traded Aug 14 Filed Aug 18
    ↗
  4. Neil Glat Director
    Buy
    $49K 8,500 shares at $5.74 +3.5% to stake
    Traded Aug 14 Filed Aug 18
    ↗
  5. Michael Ellenbogen Director
    Planned sale
    $480K 80,745 shares at $5.94 3.7% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  6. Michael Ellenbogen Director
    Planned sale
    $501K 80,745 shares at $6.21 3.7% of stake
    Traded Jun 15 Filed Jun 16
    ↗
  7. Michael Ellenbogen Director
    Planned sale
    $455K 80,745 shares at $5.63 3.7% of stake
    Traded May 15 Filed May 18
    ↗
  8. Michael Ellenbogen Director
    Planned sale
    $510K 80,745 shares at $6.32 3.7% of stake
    Traded Apr 15 Filed Apr 17
    ↗
  9. Michael Ellenbogen Director
    Planned sale
    $468K 91,771 shares at $5.10 4.2% of stake
    Traded Mar 6 Filed Mar 9
    ↗
  10. Michael Ellenbogen Director
    Planned sale
    $442K 80,745 shares at $5.47 3.7% of stake
    Traded Feb 17 Filed Feb 18
    ↗
  11. Michael Ellenbogen Director
    Planned sale
    $501K 80,745 shares at $6.20 3.7% of stake
    Traded Jan 16 Filed Jan 20
    ↗
  12. Michael Ellenbogen Director
    Planned sale
    $558K 80,745 shares at $6.91 3.7% of stake
    Traded Dec 15, 2025 Filed Dec 16, 2025
    ↗
  13. Robert E Marshall Chief Revenue Officer
    Buy
    $42K 7,000 shares at $6.06 New stake
    Traded Nov 25, 2025 Filed Nov 25, 2025
    ↗
  14. John Kedzierski CEO
    Buy
    $47K 8,000 shares at $5.91 New stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
    ↗
  15. Kevin M. Charlton Director
    Buy
    $85K 15,000 shares at $5.68 +52% to stake
    Traded Nov 21, 2025 Filed Nov 21, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 31 option exercises, 5 sales to cover taxes, and 3 sales back to the company.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
8-K 9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Gross profit $33.83M $59.29M $75.3M
Net income -$106.25M -$54.02M -$33.14M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $175.84M $138.1M $151.3M
Total non-current assets * $122.88M $141.9M $153.11M
Total assets $298.72M $280M $304.41M
Total current liabilities $82.05M $76.37M $122.98M
Total non-current liabilities * $70.35M $63.86M $62.01M
Total equity $146.32M $139.78M $119.42M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$9.8M -$30.85M $18.67M
Cash from investing -$123.11M -$1.4M -$41.83M
Cash from financing -$29.66M $1.81M $35.4M
Net change in cash -$162.62M -$30.42M $12.14M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.